Measuring Platelet Aggregation in Dialysis Patients With a Whole Blood Aggregometer by the Screen Filtration Pressure Method

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 2, 2011, Pages 203-206

  Waki, Kayo ^a   Hayashi, Aki ^a   Ikeda, Shigeo ^b   Ikeda, Sadao ^b   Nagatsuka, Kazuhiro ^b   Honma, Yoshiyuki ^b   Kadowaki, Takashi ^a   Yoshinoya, Sadayoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yamato City Hospital   (Japan)

Author keywords

Antiplatelet medication; Diabetes mellitus; Hemodialysis; Platelet aggregation; Whole blood aggregation

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANALYTICAL EQUIPMENT; ANTICOAGULANT THERAPY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PLATELET AGGREGATION THRESHOLD INDEX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREEN FILTRATION PRESSURE METHOD; THROMBOCYTE AGGREGATION; WHOLE BLOOD AGGREGOMETER;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FILTRATION; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UREMIA;

EID: 79953044865     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00899.x     Document Type: Article

References (14)

1. Ozeki Y, Sudo T, Toga K etal. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001;101:65-72.
2. Imiya M, Matsuo T. [A new parameter for evaluating platelet aggregation in patients with chronic cerebral infarction]. Rinsho Byori 1993;41:923-9.
3. Imano H, Iso H, Sato S etal. Determinants of platelet aggregation in 50-70-year-old men from three Japanese communities. Atherosclerosis 2002;165:327-34.
4. Tabuchi A, Taniguchi R, Takahashi K etal. Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method. Circ J 2008;72:420-6.
5. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95.
6. Sudo T, Ito H, Ozeki Y, Kimura Y. Estimation of antiplatelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001;133:1396-404.
7. Salobir B, Sabovic M, Zupan IP, Ponikvar JB. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients. Ther Apher Dial 2008;12:133-6.
8. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006;19:317-22.
9. Chou KJ, Jan CR, Lee PT etal. Platelet hyperreactivity in hemodialysis patients with frequently occluded vascular access. Thromb Haemost 2004;92:621-6.
10. Deykin D. Uremic bleeding. Kidney Int 1983;24:698-705.
11. Remuzzi G. Bleeding in renal failure. Lancet 1988;1:1205-8.
12. Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 2003;26:2181-8.
13. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001;24:1476-85.
14. Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001;280:H1480-9.